And now there's been a move to make all the vaccines MRNA based. Have you heard about that? You should concern. It's being used in veterinary medicine as well. That's. I think that's The MRNA platform can be such a profitable platform. You can, you know, bring out a new variety almost overnight. So they really wanted to use this. But as this, you know, oncologist pointed out, he'd been involved in research with mRNA, it never succeeded. It just never worked. (05:11–05:20)
CLAIM
Asserts that the mRNA platform is profitable and allows for rapid development of new varieties.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
